Effect of exercise on augmented aortic vasoconstriction in the db/db mouse model of type-II diabetes

Physiological Research

Volumn 57, Issue 6, 2008, Pages 1-31

  Khazaei, M ^a   Moien Afshari, F ^b   Kieffer, T J ^b   Laher, I ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; Exercise; Vasoconstriction

Indexed keywords

EID: 58849117249     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. ABEBE W, HARRIS K.H, MACLEOD K.M: Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 16: 239-248, 1990.
2. ABEBE W, MACLEOD K.M: Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Can J Physiol Pharmacol 69: 355-361, 1991.
3. AGRAWAL D.K, MCNEILL J.H: Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol 65: 1484-1490,1987.
4. ARIKAWA E, VERMA S, DUMONT A.S, MCNEILL J.H: Chronic bosentan treatment improves renal artery vascular function in diabetes. J Hypertens 19: 803-812, 2001.
5. BAE J.H, BASSENGE E, KIM K.B, KIM Y.N, KIM K.S, LEE H.J, MOON K.C, LEE M.S, PARK K.Y, SCHWEMMER M: Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155: 517-523, 2001.
6. BARTUS M, LOMNICKA M, LORKOWSKA B, FRANCZYK M, KOSTOGRYS R.B, PISULEWSKI P.M, CHLOPICKI S: Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat. Pharmacol Rep 57: 127-137, 2005.
7. BRADLEY A.B, MORGAN K.G: Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol 385: 437-448, 1987.
8. BUUS C.L, AALKJAER C, NILSSON H, JUUL B, MOLLER J.V, MULVANY M.J: Mechanisms of Ca2+ sensitization of force production by noradrenaline in rat mesenteric small arteries. J Physiol 510: 577-590,1998.
9. DE ANGELIS K, WICHI R.B, JESUS W.R, MOREIRA E.D, MORRIS M, KRIEGER E.M, IRIGOYEN M.C: Exercise training changes autonomic cardiovascular balance in mice. J Appl Physiol 96: 2174-2178, 2004.
10. GARCIA M.J, MCNAMARA P.M, GORDON T, KANNEL W.B: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105-111,1974.
11. GUO Z, SU W, ALLEN S, PANG H, DAUGHERTY A, SMART E, GONG M.C: COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735, 2005.
12. HALLER H, BAUR E, QUASS P, BEHREND M, LINDSCHAU C, DISTLER A, LUFT F.C: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47: 1057-1067, 1995.
13. HIMPENS B, KITAZAWA T, SOMLYO A.P: Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflugers Arch 417: 21-28,1990.
14. INOGUCHI T, BATTAN R, HANDLER E, SPORTSMAN J.R, HEATH W, KING G.L: Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci 89: 11059-11063, 1992.
15. JOLLIFFE J.A, REES K, TAYLOR R.S, THOMPSON D, OLDRIDGE N, EBRAHIM S: Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev CD001800, 2001.
16. KAMATA K, MIYATA N, KASUYA Y: Mechanisms of increased responses of the aorta to alpha-adrenoceptor agonists in streptozotocin-induced diabetic rats. J Pharmacobiodyn 11: 707-713,1988.
17. KAWASAKI H: Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats. Hokkaido Igaku Zasshi 72: 649-665, 1997.
18. KEEGAN A, WALBANK H, COTTER M.A, CAMERON N.E: Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 38: 1475-1478, 1995.
19. KNOWLER W.C, BARRETT-CONNOR E, FOWLER S.E, HAMMAN R.F, LACHIN J.M, WALKER E.A, NATHAN D.M: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403,2002.
20. KORZICK D.H, LAUGHLIN M.H, BOWLES D.K: Alterations in PKC signaling underlie enhanced myogenic tone in exercise-trained porcine coronary resistance arteries. J Appl Physiol 96: 1425-1432, 2004.
21. KOYA D, KING G.L: Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
22. MACLEOD K.M: The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes. Diabetes 34: 1160-1167,1985.
23. MORGAN J.P, & MORGAN K.G: Calcium and cardiovascular function. Intracellular calcium levels during contraction and relaxation of mammalian cardiac and vascular smooth muscle as detected with aequorin. Am J Med. 77: 33-46, 1984.
24. MULHERN M. & DOCHERTY J.R: Effects of experimental diabetes on the responsiveness of rat aorta. Br J Pharmacol 97: 1007-1012, 1989.
25. MYERS J, PRAKASH M, FROELICHER V, DO D, PARTINGTON S, ATWOOD J.E: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801, 2002.
26. OKON E.B, GOLBABAIE A, VAN BREEMEN C: In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors. Br J Pharmacol 137: 545-553, 2002.
27. OKON E.B, SZADO T, LAHER I, MCMANUS B, VAN BREEMEN C: Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530, 2003.
28. PAFFENBARGER R.S, HYDE R.T, WING A.L, LEE I.M, JUNG D.L, KAMPERT J.B: The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 328: 538-545, 2003.
29. PANNIRSELVAM M, SIMON V, VERMA S, ANDERSON T, TRIGGLE C.R: Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140: 701-706, 2003.
30. PANNIRSELVAM M, VERMA S, ANDERSON T.J, TRIGGLE C.R: Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136: 255-263, 2002.
31. SANDU O.A, RAGOLIA L, BEGUM N: Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 49: 2178-2189, 2000.
32. SATOH S, KREUTZ R, WILM C, GANTEN D, PFITZER G: Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells. J Clin Invest 94: 1397-1403, 1994.
33. SESSO H.D, PAFFENBARGER R.S, LEE I.M: Physical activity and coronary heart disease in men: The Harvard Alumni Health Study. Circulation 102: 975-980, 2000.
34. SOMLYO A.P, SOMLYO A.V: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177-185, 2000.
35. SPIER S.A, LAUGHLIN M.H, DELP M.D: Effects of acute and chronic exercise on vasoconstrictor responsiveness of rat abdominal aorta. J Appl Physiol 87:1752-1757,1999.
36. STEWART K.J: Exercise training: can it improve cardiovascular health in patients with type 2 diabetes? Br J Sports Med 38: 250-252, 2004a.
37. STEWART K.J: Role of exercise training on cardiovascular disease in persons who have type 2 diabetes and hypertension. Cardiol Clin 22: 569-586, 2004b.
38. TANG T, REED M.J: Exercise adds to metformin and acarbose efficacy in db/db mice. Metabolism 50:1049-1053, 2001.
39. TAYLOR P.D, OON B.B, THOMAS C.R, POSTON L: Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 111:35-41,1994.
40. TESFAMARIAM B, COHEN R.A: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263: H321-H326,1992.
41. TESFAMARIAM B, JAKUBOWSKI J.A, COHEN R.A: Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol 257: H1327-H1333, 1989.
42. VANHOUTTE P.M: Endothelin-1. A matter of life and breath. Nature 368: 693-694, 1994.
43. VERMA-AHUJA S, HUSAIN K, VERHULST S, ESPINOSA J.A, SOMANI S.M: Delayed effects of pyridostigmine and exercise training on acetylcholinesterase and muscle tension in mouse lower extremity. Arch Toxicol 74: 539-546, 2000.
44. XAVIER F.E, DAVEL A.P, ROSSONI L.V, VASSALLO D.V: Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vascul Pharmacol 40:67-76, 2003.
45. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
46. ZHU B.H, GUAN Y.Y, MIN J, HE H: Contractile responses of diabetic rat aorta to phenylephrine at different stages of diabetic duration. Acta Pharmacol Sin 22: 445-449, 2001.